Question: is this a 2) strong advice, 1) weak advice 0) no advice?

These findings are supported by the findings of an exploratory analysis of the safety and efficacy outcomes in pooled data from phase II trials of single-agent trabectedin in heavily and non-heavily pretreated patients with recurrent ovarian cancer. 
user
This is no advice
assistant